Click on image to view larger version.
Fig. 3. Targets of different drugs within the sympathetic nervous system that increase the availability of norepinephrine (NE) within the synaptic cleft (EGCG, ephedrine, amphetamine, sibutramine) or prolong NE-induced increases in lipid mobilization and oxidation (caffeine). Abbreviations: NE, norepinephrine; COMT, catechol-O-methyl transferase; ß-AR, ß-adrenoreceptor; Gs, stimulatory G-protein; PKA, protein kinase A; HSL, hormone sensitive lipase; TAG, triacylglycerol; FFA, free fatty acids; PDE, phosphodiesterase.
